Accepted Abstracts
( Poster Session )
Click Here!
Instruction for Poster Presentation
Abstract submission is now closed.
The ISNS 2013 welcomes the submission of abstracts of free papers all of which will be presented as posters. No free papers will be presented orally at podium.
General Policies
- Acceptance of abstracts will be judged by the ISNS Scientific Committee based on originality, scientific merit, study design, clarity of expression, presentation of substantial data, adherence to the rules of submission, and relevance to the topic.
- It is not necessarily restrict the topic to that of neonatal period, but those studies dealing with seizures in elder children also will be welcomed.
- The presenting author of an abstract is requested to complete the registration procedure including the fee payment, or to present a special note indicating payment guarantee. Otherwise, the abstract received will be considered as a temporary one.
- A single author or a group of authors can submit two or more abstracts on different topics.
- The abstract should be prepared in English.
- Notification of acceptance will be sent to the presenting author by January 31, 2013. Detailed instruction on how to prepare the poster presentation will also be included with this correspondence.
Abstract Format- How to prepare an abstract
- Abstract text (excluding title, authors and affiliations) must not exceed 250 words.
- Abstract title must be in CAPITAL letters. Title should be concise and indicate the content of abstract.
- Names of all co-authors, institutions, cities and countries are to be typed under the title. Author’s first or given name should be fully spelled-out and shall always be placed before the capitalized family name (i.e. Yoshiyuki OHTOMO). The presenting author should be placed top and underlined. Each author should carry the number indicating respective institution, city, and country. Do NOT include degrees or professional titles (Dr., PhD., Prof., MD, etc).
- Leave one line space between the title/author block and the body of the abstract.
- Abstract text must be single-spaced. Do not leave blank lines between paragraphs. The headings (Objectives, Methods, Results, and Conclusions) must be bolded and followed by a colon (:) and then the text.
- Neither graphs, pictures nor other types of images should be included in abstract.
- Use standard abbreviations. Place special or unusual abbreviations in parentheses after the full term when it appeared for the first time.
- As a standard font, please use Times / Times New Roman of 12 points.
Abstract submission - How to prepare an abstract
All abstracts shall be submitted via e-mail. The abstract in a word file (not pdf) should be attached to the e-mail, and send it to the ISNS Headquarter at <isns2013@k-con.co.jp>. No fax nor airmail sending will be accepted.
Deadline for submission
December 20th 2012
Abstract Submission deadline has been extended to January 23rd (Wednesday) Noon by Tokyo Time.
Sample abstract
SEVERE MYOCLONIC EPILEPSY IN INFANCY (SME) WITH A MILD CLINICAL COURSE
Masako SAKAUCHI, Hirokazu OGUNI, Yoshiko HIRANO, Makiko OSAWA Department of Pediatrics, Tokyo Women’s Medical University, Tokyo, Japan
Objective: SME, also known as Dravet syndrome, is one of the most severe epileptic syndromes afflicting infants. However, we have experienced borderline SME patients with better seizure and mental outcomes. We investigated this mild form of SME.
Method: The subjects were 17 children (M=7, F=10) meeting some of the SME criteria but who had a milder clinical course than that seen in typical SME. All 17 had drug-resistant, fever-sensitive seizures during the early clinical course. Eleven underwent SCN1A mutation analysis. We retrospectively investigated the clinical features and outcomes of these children.
Results: The onset ages, prevalences of fever-sensitivity and seizure refractoriness during infancy and early childhood did not differ from those of typical SME. There were fewer episodes of status epilepticus and fewer polymorphous seizure types than with typical SME and responses to KBr were better in most of our cases. The seizures ultimately decreased markedly in frequency before 10 years of age. Thus, the clinical course was generally milder than that of typical SME, and mental outcomes were also better. Only a mis-sense SCN1A mutation was found in 27.2% of our patients.
Conclusion: This distinct group of patients with borderline SME features and better seizure outcomes is between GEFS+ and typical SME in the conceptual framework of the SCN1A mutation syndrome.
|
